The Drug Science Podcast

Dr James (Jim) Fadiman is a pioneer of the microdosing scene. Bringing the science of microdosing to the masses in his seminal work - The Psychedelic Explorer's Guide.

Show Notes

James Fadiman is a true man of many talents. Wikipedia calls him an ‘American writer’, but actually, he’s worked in multiple fields, from psychology, through to IT and, finally, to psychedelic research.

He studied Psychology at Harvard University and obtained a PhD from Stanford University. As a graduate student at Stanford, Fadiman was Stewart Brand's LSD guide on Brand's first LSD trip, at Myron Stolaroff's International Foundation for Advanced Study in Menlo Park, California.

He was also part of the team in the psychedelics in problem-solving experiment at the International Foundation for Advanced Study, which was abruptly halted in 1966 together with all the remarkable psychedelic research that was happening in the US.
 
Additionally, Fadiman worked at Stanford's Augmentation Research Center, a division that did research on networked computing. What did the technological research group need a psychologist in their team for? How are psychedelics and technological advances interconnected? And finally, what happens when you give psychedelics to a group of scientists? Listen to this week’s episode to find out!
 
Richard Alpert (Baba Ram Dass)

Psilocybin

Timothy Leary

Aldous Huxley

International Foundation for Advanced Study

Myron Stolaroff

LSD

Brandeis University

Willis Harman

PTSD

Set and setting

Mescaline 

Doug Engelbart

The Mother of All Demos

Nixon’s War on drugs

Abraham Maslow

Microdosing

microdosingpsychedelics.com 

FDA

Double-blind studies

Lupus

★ Support this podcast ★

What is The Drug Science Podcast?

Professor David Nutt has spent a career making the argument for a rational, evidence-based approach to drug policy and drug use. The scientific evidence still challenges perceived wisdom on drugs and for that reason can appear to be contentious. In this podcast, the Professor explores the actual harms and potential benefits of various drugs, challenging myths surrounding classification and legislation, and exploring the societal impact of poorly informed drug policy. Using evidence in public policy should not be controversial. A podcast for anyone interested in understanding the scientific truth about drugs, free from political or moral concern.